Deferred Tax Assets, Operating Loss Carryforwards of Alzamend Neuro, Inc. from 30 Apr 2020 to 30 Apr 2025

Taxonomy & unit: us-gaap: USD
Description: Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary: Alzamend Neuro, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 30 Apr 2020 to 30 Apr 2025.
Alzamend Neuro, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 30 Apr 2025 was $10,566,664, a 2.5% decline year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)

Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

Alzamend Neuro, Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$10,566,664	-$271,748	-2.5%	30 Apr 2025	10-K	22 Jul 2025	2025	FY
Q1 2024	$10,838,412	+$3,952,984	+57%	30 Apr 2024	10-K	22 Jul 2025	2025	FY
Q1 2023	$6,885,428	-$1,491,111	-18%	30 Apr 2023	10-K	30 Jul 2024	2024	FY
Q1 2022	$8,376,539	+$5,016,158	+149%	30 Apr 2022	10-K	27 Jul 2023	2023	FY
Q1 2021	$3,360,381	+$1,027,180	+44%	30 Apr 2021	10-K	19 Jul 2022	2022	FY
Q1 2020	$2,333,201			30 Apr 2020	10-K	29 Jul 2021	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.